title: Comparison of 18F FDOPA PET, DSC-MRI and spectroscopy in a patient with brain metastatic lesions from lung cancer.
authors.affiliation: IRCCS Neuromed, Pozzilli, Italy. Electronic address: agostino.chiaravalloti@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Chiaravalloti
authors.affiliation: Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Floris
authors.affiliation: IRCCS Neuromed, Pozzilli, Italy; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
authors.forename: O
authors.initials: O
authors.lastname: Schillaci
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging* / Q000556:secondary; D001932:Brain Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D003287:Contrast Media; D004295:Dihydroxyphenylalanine; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy; D008536:Meglumine / Q000031:analogs & derivatives; D009942:Organometallic Compounds; D000072078:Positron Emission Tomography Computed Tomography; D019275:Radiopharmaceuticals; D013057:Spectrum Analysis
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C064572:gadobenic acid; D004295:Dihydroxyphenylalanine; D008536:Meglumine